RMDM Group is excited to announce that their liquid biopsy PanTum Detect® Early Cancer Detection blood test is officially live at the Doctors Centre Polyclinic in Dubai.
London. 24th June 2025 — RMDM, a partner in Doctors Centre Polyclinic, introduces an early cancer detection blood test programme. The partnership aims to leverage their combined resources and expertise to enhance early diagnosis, revolutionising the landscape of preventive healthcare in the UAE and beyond.
PanTum Detect® is a groundbreaking Early Cancer detection blood test developed in Germany. The test is built on the pioneering work by Dr Johannes Coy, most notably known as the discoverer of the TKTL1 gene, which explains the uptake of glucose from cancer cells when they proliferate and lead to metastasis (Warburg Effect).
RMDM’s PanTum Detect® liquid biopsy is able to identify tumour-related changes in the immune system, helping to flag abnormal cell activity at a much earlier stage, when treatment is more effective and options are broader. As the first point of information, this innovative approach allows detection of potential cancer activity before it becomes clinically visible through imaging or symptoms. It’s particularly useful for individuals who are at higher risk, have a family history of cancer, or simply want to take a more proactive role in managing their long-term health.
Bringing revolutionary early cancer screening to the United Arab Emirates, PanTum Detect® is now local and easily accessible to the Middle East and North Africa (MENA) region.
Dubai continues to position itself as a global hub for healthcare innovation. By making PanTum Detect® available at the Doctors Centre Polyclinic, a well-established and trusted medical provider, we’re making advanced diagnostics more accessible to the local population and international visitors alike.
This launch also reflects RMDM’s wider commitment to combining cutting-edge science with holistic healthcare, empowering people with the tools and knowledge they need to live longer, healthier lives.
Whether you’re focused on prevention or concerned about your health status, PanTum Detect® helps offer a new level of clarity and peace of mind.
We’re proud to bring this powerful tool to the UAE and look forward to supporting doctors and healthcare providers as we move toward a more preventative approach to cancer care.
About RMDM Group:
RMDM Group is a UK-based one-stop-shop for cancer diagnostics, prevention and treatment.
We use ground-breaking technology to provide healthcare partners worldwide with non-invasive, low cost and highly accurate early intervention diagnostic tools.
Established in 2017, RMDM is founded on the principles of world-renowned cancer research scientist Dr Johannes Coy , who discovered the TKTL1 gene. Our purpose is to harness the power of cutting-edge research and technology to provide practical and affordable interventions to support health and wellbeing, focusing particularly on diagnostics and metabolism. The revolutionary PanTum Detect test is one such example.
Through our commitment to rigorous research and scientific collaboration, we work to translate evidence into practice in a way that positively disrupts the health and wellbeing industry.
Media Contact:
Name: Priyank Morijara
Organization: RMDM Group
Address: 1 Knightsbridge Green, London, SW1X 7QA, United Kingdom
Phone: +44(0)207 052 8353
Email: [email protected]
Website: https://rmdm.group/
